46,470 Shares in Agilent Technologies, Inc. $A Bought by Rakuten Investment Management Inc.

Rakuten Investment Management Inc. bought a new stake in Agilent Technologies, Inc. (NYSE:A) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 46,470 shares of the medical research company’s stock, valued at approximately $6,173,000.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in A. Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in Agilent Technologies by 4.3% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 599,581 shares of the medical research company’s stock valued at $82,712,000 after buying an additional 24,687 shares in the last quarter. Bank of Nova Scotia acquired a new position in shares of Agilent Technologies during the 2nd quarter worth about $58,539,000. Dudley & Shanley Inc. lifted its stake in Agilent Technologies by 25.9% in the second quarter. Dudley & Shanley Inc. now owns 69,500 shares of the medical research company’s stock valued at $9,232,000 after buying an additional 14,300 shares during the last quarter. BIP Wealth LLC purchased a new position in Agilent Technologies in the 2nd quarter valued at $834,000. Finally, Crossmark Global Holdings Inc. raised its stake in shares of Agilent Technologies by 39.6% during the 4th quarter. Crossmark Global Holdings Inc. now owns 33,918 shares of the medical research company’s stock worth $4,615,000 after buying an additional 9,615 shares in the last quarter.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on A shares. Citigroup increased their target price on Agilent Technologies from $185.00 to $190.00 and gave the company a “buy” rating in a report on Thursday. Wolfe Research reiterated a “hold” rating on shares of Agilent Technologies in a report on Tuesday, June 2nd. Bank of America upped their price objective on shares of Agilent Technologies from $155.00 to $180.00 and gave the company a “buy” rating in a research note on Thursday. Robert W. Baird lifted their target price on shares of Agilent Technologies from $155.00 to $156.00 and gave the stock an “outperform” rating in a research note on Tuesday, May 26th. Finally, Stifel Nicolaus boosted their price target on Agilent Technologies from $170.00 to $180.00 and gave the company a “buy” rating in a report on Thursday. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $170.33.

Agilent Technologies Trading Down 2.0%

NYSE A opened at $154.47 on Friday. The firm has a market capitalization of $43.63 billion, a price-to-earnings ratio of 30.41, a PEG ratio of 2.65 and a beta of 1.25. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.62 and a current ratio of 2.05. Agilent Technologies, Inc. has a one year low of $108.35 and a one year high of $163.75. The company’s 50 day moving average price is $140.30 and its 200 day moving average price is $127.04.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.49 by $0.13. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The company had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.84 billion. During the same period in the previous year, the firm earned $1.37 earnings per share. Agilent Technologies’s revenue for the quarter was up 8.1% on a year-over-year basis. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, sell-side analysts predict that Agilent Technologies, Inc. will post 6.2 EPS for the current year.

More Agilent Technologies News

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent reported fiscal Q3 earnings of $1.62 per share, above the $1.48-$1.49 analyst consensus, while revenue of approximately $1.88 billion also exceeded expectations. EPS increased from $1.37 a year earlier, supporting the view that profitability is improving. Agilent Technologies Q3 Earnings and Revenues Top Estimates
• Positive Sentiment: Management raised its full-year guidance following the strong quarter. Commentary highlighted product momentum, a recovery in China, improving demand and expanding margins, all of which could support additional earnings growth. Agilent Technologies Lifts Outlook After Strong Quarter
• Positive Sentiment: Several major firms raised their price targets and maintained bullish ratings after the results. Targets now range from $175 to $190, with upgrades from JPMorgan, Citi, Barclays, Goldman Sachs, Bank of America, Stifel, TD Cowen, Bernstein and RBC. Analysts Raise Agilent Technologies Price Targets
• Neutral Sentiment: Despite the improved outlook, valuation remains relatively demanding: Agilent trades at roughly 30 times earnings, with a PEG ratio above 2.7. This leaves the stock sensitive to any slowdown in demand or disappointment in future guidance.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.